CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/11/2022
Voltar para busca
Dado oficial do USPTO
AI IS WHERE THE DATA IS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AI IS WHERE THE DATA IS
ST13
US500000090812123Classe
9, 35, 42, 44
Pedido
90812123
Registro
6693951
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
02/11/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 42, 44
Data de depósito
06/07/2021
Data de registro
05/04/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/04/2022
Última transação
02/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Tübingen, DE
Examinador
ANDERSON, CASSONDRA CR
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH
Representantes
Anna Kurian Shaw Hogan Lovells US LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysisdeveloping personal treatment strategies for patients with diagnosed canceranalyzingscreeningidentifyingquantifyinginterpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software
Classe 35
Statistical services and modeling with respect to cancer treatment and cancer diagnosis
Classe 42
Computer programming in the medicalpharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technologycancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposesfor the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biologycancer treatmentpharmaceutical side effectsgenomicscancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an onlinenon-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology
Classe 44
Medical and pharmaceutical services
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/01/2022
PUBO
PUBLISHED FOR OPPOSITION
18/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2021
ALIE
ASSIGNED TO LIE
09/12/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/12/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21/09/2021
GNSL
LETTER OF SUSPENSION E-MAILED
21/09/2021
CNSL
SUSPENSION LETTER WRITTEN
21/09/2021
DOCK
ASSIGNED TO EXAMINER
21/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/09/2021
NWAP
NEW APPLICATION ENTERED
09/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AI IS WHERE THE DATA IS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.